UBS O'Connor’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

UBS O'Connor’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-237,619	Closed	-$2.38M	–	885
2022 Q3	$2.38M	Sell	237,619 -23,888	-9%	-$238K	0.03%	533
2022 Q2	$2.59M	Buy	+261,507	New	+$2.58M	0.03%	531
2022 Q1	–	Sell	-256,881	Closed	-$2.52M	–	760
2021 Q4	$2.52M	Buy	256,881 +6,890	+3%	+$67.9K	0.02%	501
2021 Q3	$2.45M	Hold	249,991	–	–	0.02%	482
2021 Q2	$2.47M	Hold	249,991	–	–	0.02%	421
2021 Q1	$2.57M	Buy	+249,991	New	+$2.78M	0.04%	397

UBS O'Connor's LUXA Position: Q4 2022 in Review

UBS O'Connor sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 237,619 shares — an estimated $2.38M sold.

UBS O'Connor first reported a position in LUXA in Q1 2021 and held it in 6 quarters. The position peaked at $2.59M in Q2 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

UBS O'Connor reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 237,619 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.38M.
UBS O'Connor first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 6 quarters.
UBS O'Connor's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $2.59M in Q2 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.